Pay in 4 interest-free payments of $6.84 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
Defective human spermatozoa are characterized by an abnormally high fatty acid content that, in their unesterified, unsaturated form, promote the generation of reactive oxygen species by sperm mitochondria, thus creating a state of oxidative stress with a concomitant loss of functional competence
Enhances detoxification processes in the body
The most common side effects include mild discomfort, redness, or swelling at the injection site
Anticipated Costs Post-Approval While neither compound has reached market, pricing for similar medications provides context: Semaglutide (Wegovy) Approximately $1,300-$1,500 monthly without insurance Tirzepatide (Zepbound) Approximately $1,000-$1,200 monthly without insurance Cagrilintide and retatrutide would likely fall in similar price ranges, with combination therapy potentially costing $2,000-$3,000 monthly without insurance coverage
US$ 26.86
US$ 26.47
US$ 21.32
US$ 21.27
US$ 25.61
US$ 25.35